UC Scientist Wins Parkinson's Research Award
Kim Seroogy, PhD, professor in the UC Department of Neurology, has received a $250,000 grant from the Michael J. Fox Foundations 2004 Community Fast Track Program.
Dr. Seroogys team in the Selma Schottenstein Harris Laboratory for Research in Parkinsons Disease at UC will study the potential therapeutic value of two proteins from the neuregulin family of growth factors. Their goal is to identify the best candidate for future preclinical testing.
Six national and local Parkinsons disease groups and a charitable trust teamed with the Fox Foundation to award more than $3.6 million to 18 outstanding researchers around the world.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.